Abiosciences
PrivateLast Round
Series A++
May 25, 2021
Company Overview
Abiosciences is a biotechnology company that provides single-cell genomic sequencing, bioinformatics analysis, and therapeutic target discovery services for the life sciences and pharmaceutical industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Healthcare Analytics, Data Visualization
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abiosciences Comparables
Compare Abiosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Scailyte AG | 87% | |
| One Biosciences | 83% | |
| Ozette | 80% | |
Abiosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A++ | May 25, 2021 | ||||
| Strategic | Feb 1, 2021 | ||||
| Series A Extension | Dec 29, 2020 | ||||
| Series A | Jun 1, 2019 |
Abiosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IDG Capital | Series A Extension, Series A++, Series A |
| Primavera Venture Partners | Series A++ |
| 松禾资本 (Green Pine Capital Partners) | Series A++ |
| HongShan Capital Group (HSG) | Series A++ |
| SB China Capital | Series A Extension |
| Apricot Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 25, 2021
Led by HongShan Capital Group (HSG) with participation from Primavera Venture Partners, IDG Capital, and Green Pine Capital Partners.
Abiosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Abiosciences's valuation, stock price, and market status.